0 CHECKOUT

PRODUCT FILTERS

REGION

CATEGORIES

  • 5
  • 1
  • 1
  • 1
  • 1

PRICE

5
5
5
6

PUBLISHED

0
1
3
6

PRODUCT TYPE

3
2
1

Search for: "Novelos Therapeutics Inc-Therapeutic Competitors"

Novelos Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain...

Published:  May 2015
Price:  From

Novelos Therapeutics, Inc. (NVLT) - Financial and Strategic SWOT Analysis Review

Summary Novelos Therapeutics, Inc. (Novelos) is a US-based pharmaceutical company. It undertakes the development of novel drugs for the treatment and diagnosis of cancer. The company's therapeutic...

Published:  April 2013
Price:  From

Cellectar Biosciences, Inc. (formerly Novelos Therapeutics, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

The Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization...

Published:  March 2016
Price:  From

Cellectar Biosciences, Inc. (CLRB) - Financial and Strategic SWOT Analysis Review

Cellectar Biosciences, Inc. (CLRB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

Published:  January 2016
Price:  From

OncoVista Innovative Therapies, Inc. (OVIT) - Financial and Strategic SWOT Analysis Review

OncoVista Innovative Therapies, Inc. (OVIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has...

Published:  June 2015
Price:  From

Anti-Infectives: World Market, 2nd Edition, Vol III: Antivirals

This third volume of Kalorama Information’s World Market for Anti-Infectives series, the 2nd. Edition focuses on three general product segments of antiviral treatment: Nucleoside Analogs Protease...

Published:  May 2007
Price:  From
Loading Indicator

Our Clients

  • Dow Chemical Co Ltd.
  • The Estee Lauder Companies Inc
  • Carrefour S.A.
  • Motorola Solutions, Inc.
  • Activision Publishing, Inc.
  • 3M Company